期刊
NANOMEDICINE
卷 6, 期 1, 页码 55-68出版社
FUTURE MEDICINE LTD
DOI: 10.2217/NNM.10.99
关键词
cancer; HK97; protein conjugation; targeted cellular entry; transferrin; viral nanoparticles
资金
- American Heart Association
- NIH [K99EB009105, R01CA112075, 2R01-AI40101]
- NATIONAL CANCER INSTITUTE [R01CA112075] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040101] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [K99EB009105, R00EB009105] Funding Source: NIH RePORTER
Aims: Next-generation targeted nanodevices are currently under development for imaging and therapeutic applications. We engineered HK97 viral nanoparticles (VNPs) for tumor cell-specific targeting. Methods: A combination of genetic and chemical engineering methods were developed and applied to generate dual-labeled HK97 cysteine mutant particles displaying transferrin and fluorescent labels. The targeting properties of transferrin-conjugated VNPs were evaluated by in vitro experiments using different cancer cell lines. Results: We found that HK97-tranferrin formulations were indeed targeted to cancer cells in vitro via the transferrin receptor. These studies highlight the utility and facilitate the further development of HK97-based VNPs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据